BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Zanamivir

A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.

297+ PubMed studies analyzed · 31 RCTs · Evidence Score: 50.2

Research Domains

Zanamivir has been studied across 10 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🫁 Respiratory, 🔬 Oncology, ⏳ Longevity & Aging. The primary research focus is 🫘 Kidney with 6% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Zanamivir, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Oseltamivir
3 shared targets
neu5ac2en
2 shared targets
Gabapentin
2 shared targets
Hydromorphone
2 shared targets
trolox
2 shared targets
Nitroarginine
2 shared targets
Oxytocin
2 shared targets
Pregabalin
2 shared targets
hydrocodone
2 shared targets
Lamivudine
2 shared targets
Loading evidence profile...

This evidence profile for Zanamivir is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.